Clinical and biochemical findings in 7 patients with X-linked adrenoleukodystrophy treated with Lorenzo's Oil
Open Access
- 1 December 2000
- journal article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 23 (4), 697-701
- https://doi.org/10.1590/s1415-47572000000400001
Abstract
X-Linked adrenoleukodystrophy (X-ALD) is a hereditary disorder of the peroxisomal metabolism biochemically characterized by the accumulation of very long chain fatty acids (VLCFA) in tissues and biological fluids. The major accumulated acids are hexacosanoic acid (C26:0) and tetracosanoic acid (C24:0). The disorder is characterized clinically by central and peripheral demyelination and adrenal insufficiency closely related to the accumulation of fatty acids. The incidence of X-ALD is estimated to be 1:25,000 males. At least six phenotypes can be distinguished. The most common phenotypes are childhood cerebral ALD and adrenomyeloneuropathy (AMN). The recommended therapy consists of the use of the glyceroltrioleate/glyceroltrierucate (GTO/GTE) mixture, known as Lorenzo's Oil, combined with a VLCFA-poor diet. There are alternative treatments such as bone marrow transplantation and immunosuppression, as well as the use of lovastatin and sodium phenylacetate. In the present study we report the clinical and biochemical course of 7 male patients with X-ALD treated with Lorenzo's Oil and a VLCFA-restricted diet. Treatment produced 50% reduction in C26:0 and 42.8% reduction in the C26:0/C22:0 ratio. Most patients remained clinically well, although approximately 30% of them presented a rapid clinical deterioration. The results showed a poor biochemical-clinical correlation for treatment, indicating that new therapies for X-ALD are needed in order to obtain a better prognosis for patients.Keywords
This publication has 14 references indexed in Scilit:
- Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophyNeurology, 1999
- Adrenoleukodystrophy protein enhances association of very long-chain acyl-coenzyme A synthetase with the peroxisomeNeurology, 1999
- X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapyJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Glycerol trioleate/glycerol trierucate therapy in X‐linked adrenoleukodystrophy: Saturated and unsaturated fatty acids in blood cells. Implications for the follow‐upJournal of Inherited Metabolic Disease, 1996
- Peroxisomal Disorders: A ReviewJournal of Neuropathology and Experimental Neurology, 1995
- Adrenoleukodystrophy: natural history, treatment and outcomeJournal of Inherited Metabolic Disease, 1995
- Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: Effect on clinical, biochemical and neurophysiological parametersEuropean Journal of Pediatrics, 1995
- Postnatal diagnosis of peroxisomal disorders: A biochemical approachBiochimie, 1993
- Adrenoleukodystrophy: Phenotypic variability and implications for therapyJournal of Inherited Metabolic Disease, 1992
- X‐linked adrenoleukodystrophy: Biochemical diagnosis and enzyme defectJournal of Inherited Metabolic Disease, 1992